Microbiome in Critical Illness: Sepsis, COVID-19, Paediatrics and Treatment Strategies

Start:

Tue, 12 Oct 2021, 04:00

End:

Tue, 12 Oct 2021, 06:00

Website:

https://iii.hm/wr21

Venue:

Moderator

PROF. DR. JAN DE WAELE

Intensivist

Dept. of Critical Care Medicine

Surgical Intensive Care Unit

Ghent University Hospital

Topics & Panellists

Topic: Microbiome in Sepsis and COVID-19

FRANCESCO FORORI

Professor of Anaesthesia and Intensive Care

Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine

University of Pisa

Pisa, Italy

SAMUELE FERRARI

Medical Doctor

Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine

University of Pisa

Pisa, Italy

Topic: Potential Microbiome Treatments in Critical Illness (specifically fibre and SCFAs).

NATHAN J. LINGESMITH

Surgical Critical Care Fellow

Department of Surgery and

Emory Critical Care Center

Emory University School of

Medicine

Atlanta, Georgia, USA

Topic: Respiratory Microbiota in Paediatric Patients and its Relation with Ventilator Associated Pneumonia

CARMINA GUITART

Intensive Care Unit Fellow

Paediatric Intensive Care Unit

Hospital Sant Joan de Déu

University of Barcelona

Paediatric and Neonatal Transport Unit Hospital Sant Joan de Déu

University of Barcelona

Immunological and Respiratory Disorders Paediatric Critical Patient Research Group

Research Institute of Sant Joan de Déu University of Barcelona

Barcelona, Spain

Topic: Microbiome and Probiotics: Do They Really Work

YAROSLAVA LONGHITANO

Consultant

Department of Anesthesiology and Critical Care Medicine

Azienda Ospedaliera SS

Antonio e Biagio e Cesare Arrigo

Alessandria, Italy

Topic: The Dysbiosis-COVID-19 Dilemma

JAVIER MANCILLA-GALINDO

Unidad de Investigación

UNAM-INC

Instituto Nacional de Cardiología - Ignacio Chávez

Mexico City, México

Find ICU Management On Social Media

Exhibit

Symposia

Workshops

Organiser

The microbiota is recognised as one of the most important factors that can worsen the clinical conditions of patients who are already very frail in the intensive care unit. At the same time, it is important to consider the positive side of the bacterial coin. Join our panellists as they discuss the role of microbiome in critical illness, possible complications in sepsis, COVID-19 and paediatric patients, and potential microbiome treatment strategies and approaches.